An interventional study of Secure message reminder in Hypertension, sponsored by Kaiser Permanente. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2013-09-27.
Sponsored by Kaiser Permanente · Not applicable, Interventional, and Health services research
This study will assess whether adding a secure message reminder to routine care improves the percentage of patients who complete a follow-up appointment with a new, documented blood pressure reading.
Hypertension is one of the leading risk factors for cardiovascular disease. Optimizing blood pressure management can help prevent adverse cardiovascular outcomes. The National Committee for Quality Assurance (NCQA) defines blood pressure control as less than 140/90 mmHg. Per this definition, less than half of Americans with hypertension are considered controlled. Literature has been published describing several ways of improving blood pressure management, but results have been variable.
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's enrollment of 182 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.
Browse Hypertension studies →Kaiser Permanente is the lead sponsor of 385 studies on the registry; 41 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 3 (50%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Routine care, no intervention
Will receive a secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure
Other: Secure message reminder
Single secure message reminder asking subjects to schedule an appointment with their provider or make a nurse visit to follow-up on their blood pressure
Appointment with new blood pressure reading
Percentage of patients who complete an appointment with a new documented blood pressure reading within six weeks after distributing the secure message reminder
Time frame: 6 weeks
New appointment with new blood pressure reading
Time frame: 6 weeks
Existing appointment kept with new blood pressure reading
Time frame: 6 weeks
Change in antihypertensive regimen
Time frame: 6 weeks
This study is completed, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kaiser Permanente